The global enteral feeding formulas market is projected to reach USD 5.95 Billion by 2020, at a CAGR of 7.6% from 2015 to 2020. The enteral feeding formulas market witnessed substantial growth in the past few years, which had a positive impact on the overall growth of the market.

The global enteral feeding formulas market is mainly driven by the rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. However, factors such as complications associated with enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of the enteral feeding formulas market to a certain extent.

Geographically, the market in North America and Europe is growing at a significant rate owing to the rising geriatric population along with increasing incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare in these regions. The Asia-Pacific region however is expected to become the growth center for the enteral feeding formulas market. The market in Japan, China, and India is likely to witness significant growth during the forecast period, owing to the presence of a large patient pool for chronic diseases and disorders, high incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in these countries.

In 2015, the major players in the global enteral feeding formulas market accounted for more than half of the market share. In order to maintain their market shares, major players focus on new product launches expansions, partnerships, agreements, and collaboration and acquisitions as key growth strategies. Of all these strategies, new product launches and expansions were the key strategies adopted by the major market players in 2015.

On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to high prevalence of malnutrition among cancer patients. Hospitals are the largest end users of enteral feeding formulas, followed by long-term care facilities. Growth in these end-user markets can mainly be attributed to the rapidly growing geriatric population and increasing prevalence of chronic disease and disorders.

Some of the prominent players in the global enteral feeding formulas market are Abbott Laboratories (U.S.), Nestl� S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).

Scope of the Report

Enteral feeding formulas are nutritional replacement products that assist in the nutritive and metabolic processes of the body, in order to maintain adequate weight and strength corresponding to the overall health status of an individual. These formulas are extensively used in hospitals and long-term care facilities. Based on product type, enteral feeding formulas are classified as standard formulas and disease-specific formulas.

Enteral Feeding Formulas Market

This research report categorizes the enteral feeding formulas market into the following segments:

Global Enteral Feeding Formulas Market, by Product Standard Formulas Polymeric Formulas Monomeric Formulas Disease-specific Formulas Diabetic Formulas Renal Formulas Hepatic Formulas Pulmonary Formulas Other Formulas

Global Enteral Feeding Formulas Market, by Stage Adults Pediatrics

Global Enteral feeding formulas Market, by Application Oncology Gastroenterology Neurology Diabetes Critical Care Other Applications

Global Enteral feeding formulas Market, by End User Hospitals Long-term Care Facilities Homecare Agencies & Hospices Nursing Homes Assisted Living Facilities

Global Enteral feeding formulas Market, by Region North America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe (RoE) Asia-Pacific (APAC) China Japan India Rest of APAC Rest of the World (RoW) Latin America Middle East & Africa



Target Audience

Manufacturers and vendors of enteral feeding formulas

Research associations related to enteral nutrition and gastroenterology

Hospitals and LTC facilities

Various research and consulting firms

Distributors of enteral feeding formulas

Healthcare institutions

Research institutes

Venture capitalists and investors

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Additional Market Segmentation

Global enteral feeding formulas market, by route of administration

Geographic Analysis

Further breakdown of the Rest of Asia-Pacific enteral feeding formulas market into South Korea, Australia, New Zealand, and others

Further breakdown of the Latin American enteral feeding formulas market into Brazil, Argentina, and the Rest of Latin America

The global enteral feeding formulas market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period. The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. On the other hand, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some factors that are expected to limit the growth of the enteral feeding formulas market in the coming years.

The global enteral feeding formulas market is segmented on the basis of product, stage, application, end user, and region.

On the basis of product, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among cancer patients. By end user, the market is segmented into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies & hospices, nursing homes, and assisted living facilities.

The global enteral feeding formulas market is further divided into four major regions�North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. North America accounted for the largest regional market in 2015, followed by Europe, Asia-Pacific, and the RoW. North America and Europe are expected to witness a healthy growth rate in the coming years, owing to the rapidly growing geriatric population along with rising incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare. The Asia-Pacific region, on the other hand, represents the fastest-growing market for enteral feeding formulas. The high growth rate in this market is primarily attributed to the presence of a large patient pool for chronic diseases and disorders, increasing incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and a rapidly increasing population in the emerging APAC countries.